Total: £ 56.28
2025-04-10 | Pages: 96 | Tables: 97
The global market for L-(+)-Ergothioneine was valued at US$ 63.5 million in the year 2024 and is projected to reach a revised size of US$ 161 million by 2031, growing at a CAGR of 14.5% during the forecast period.L-(+)-Ergothioneine (CAS 58511-63-0) ...
2025-04-10 | Pages: 73 | Tables: 71
The global market for Estriol was valued at US$ 3.3 million in the year 2024 and is projected to reach a revised size of US$ 4.3 million by 2031, growing at a CAGR of 4.2% during the forecast period.Estriol is a metabolite of estradiol and estrone. I...
2025-04-10 | Pages: 83 | Tables: 85
The global market for Troponin was valued at US$ 1690 million in the year 2024 and is projected to reach a revised size of US$ 3006 million by 2031, growing at a CAGR of 8.7% during the forecast period.Troponin, or the troponin complex, is a complex ...
2025-04-10 | Pages: 96 | Tables: 95
The global market for Mesalamine was valued at US$ 186 million in the year 2024 and is projected to reach a revised size of US$ 239 million by 2031, growing at a CAGR of 3.7% during the forecast period.Mesalamine also known as mesalamine, or 5-aminos...
2025-04-10 | Pages: 93 | Tables: 90
The global market for Orally Disintegrating Tablet was valued at US$ 17300 million in the year 2024 and is projected to reach a revised size of US$ 37140 million by 2031, growing at a CAGR of 11.7% during the forecast period.An orally disintegrating ...
2025-04-10 | Pages: 79 | Tables: 81
The global market for Fusidic Acid was valued at US$ 215 million in the year 2024 and is projected to reach a revised size of US$ 325 million by 2031, growing at a CAGR of 6.1% during the forecast period.Fusidic acid, also known as fusidin, is an ant...
2025-04-10 | Pages: 94 | Tables: 97
The global market for Medical Grade Chitosan was valued at US$ 39.5 million in the year 2024 and is projected to reach a revised size of US$ 66.3 million by 2031, growing at a CAGR of 7.8% during the forecast period.Chitosan (CS) is a linear polysacc...
2025-04-10 | Pages: 72 | Tables: 68
The global market for Adrenoleukodystrophy Drugs was valued at US$ 453 million in the year 2024 and is projected to reach a revised size of US$ 1254 million by 2031, growing at a CAGR of 15.9% during the forecast period.Adrenoleukodystrophy (ALD) is ...
2025-04-10 | Pages: 92 | Tables: 91
The global market for Fir Essential Oil was valued at US$ 49.6 million in the year 2024 and is projected to reach a revised size of US$ 88.2 million by 2031, growing at a CAGR of 8.7% during the forecast period.Fir (Abies) trees are a genus of 48–56 ...
2025-04-10 | Pages: 73 | Tables: 67
The global market for Vinyl Versatate was valued at US$ 476 million in the year 2024 and is projected to reach a revised size of US$ 907 million by 2031, growing at a CAGR of 9.8% during the forecast period.In the 1950s, Dr. Herbert Koch from the Max...
2025-04-10 | Pages: 97 | Tables: 88
The global market for Vitamin B12 (Cobalamin, Cyanocobalamin) was valued at US$ 441 million in the year 2024 and is projected to reach a revised size of US$ 537 million by 2031, growing at a CAGR of 2.9% during the forecast period.Vitamin B12 is a nu...
2025-04-10 | Pages: 95 | Tables: 96
The global market for Sepsis Treatment was valued at US$ 3814 million in the year 2024 and is projected to reach a revised size of US$ 5967 million by 2031, growing at a CAGR of 6.7% during the forecast period.Sepsis is usually treated with intraveno...
2025-04-10 | Pages: 85 | Tables: 80
The global market for Cyclophosphamide was valued at US$ 671 million in the year 2024 and is projected to reach a revised size of US$ 774 million by 2031, growing at a CAGR of 2.1% during the forecast period.Cyclophosphamide (CP), also known as cytop...
2025-04-10 | Pages: 91 | Tables: 96
The global market for Codeine was valued at US$ 244 million in the year 2024 and is projected to reach a revised size of US$ 165 million by 2031, growing at a CAGR of -5.5% during the forecast period.Codeine is an opiate used to treat pain, coughing,...
2025-04-10 | Pages: 82 | Tables: 78
The global market for Conjugate Vaccine was valued at US$ 10640 million in the year 2024 and is projected to reach a revised size of US$ 13220 million by 2031, growing at a CAGR of 3.2% during the forecast period.Vaccines are used to prevent diseases...